Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of control and FK866-treated ILC2s in vitro

ABSTRACT: RNA-seq of control and FK866-treated ILC2s in vitro

PROVIDER: PRJNA903374 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22346891_1.fastq.gz	Fastqsanger.gz
	SRR22346891_2.fastq.gz	Fastqsanger.gz
	SRR22346892_1.fastq.gz	Fastqsanger.gz
	SRR22346892_2.fastq.gz	Fastqsanger.gz
	SRR22346893_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

RNA-seq of control and FK866-treated ILC2s in vitro

Project description:To investigate the effect of NAD+ metabolism on ILC2s function, sorted ILC2s from the gut were treated with NAMPT inhibitor FK866 for bulk RNA sequcecing.

2022-11-22 | GSE218368 | GEO

CUT&Tag seq of control, FK866-, FK866 plus succinate-treated ILC2s in vitro

Project description:To investigate the effect of NAD+ metabolism on ILC2s, sorted ILC2s from the gut were treated with FK866 or FK866 plus succinate for CUT-Tag sequcecing.

2024-03-12 | GSE261263 | GEO

CUT&Tag seq of control, FK866-, FK866 plus succinate-treated ILC2s in vitro

Project description:CUT&Tag seq of control, FK866-, FK866 plus succinate-treated ILC2s in vitro

| PRJNA1086184 | ENA

RNA-seq of control and IL-33-treated WT and STAT KO ILC2s in vitro

Project description:RNA-seq of control and IL-33-treated WT and STAT KO ILC2s in vitro

| PRJNA699233 | ENA

RNA sequencing for the toyocamycin- or vehicle-treated ILC2s in vitro

Project description:RNA sequencing for the toyocamycin- or vehicle-treated ILC2s in vitro

| PRJNA1115216 | ENA

RNA sequencing for the toyocamycin- or vehicle-treated ILC2s in vitro

Project description:RNA sequencing was performed for the toyocamycin- or vehicle-treated ILC2s sorted from the large intestine of C57BL/6 mice (n = 3 per group).

2024-05-28 | GSE268233 | GEO

Microarray transcription of murine lung and uterine group 2 innate lymphoid cells (ILC2s) cultured in vitro with or without 17beta-estradiol (estrogen, E2)

Project description:This experiment sought to determine whether estrogen could directly activate changes in gene transcription in lung and uterine ILC2s, whether such changes differed between lung and uterine ILC2s, and compared baseline gene expression between ILC2s from those organs. ILC2s, defined as lineage (CD3e, CD14, CD16/32 and B220) negative, CD25 positive and CD44 high lymphocytes, were sorted by flow cytometry from 8-12 week old BALB/c mice and cultured overnight in RPMI 1640 with 10% charcoal/dextran treated calf serum in the absence or presence of 100 ng/ml estrogen. RNA was extracted from the cells after culture.

2017-10-17 | E-MTAB-5789 | biostudies-arrayexpress

RNA sequencing of mesenteric lymph node ILC2s from non-treated mice

Project description:Transcriptomes of ILC2s sorted as KLRG1+CD127+CD90+Lin-CD45+ cells from mesenteric lymph nodes of non-treated mice were analyzed. The mice were part of the experiments described in PMID: 29496881 and were sequenced together with samples submitted in GSE108884.

2021-04-27 | GSE173424 | GEO

Expression data from naive, effector and memory-like ILC2s isolated from mouse lungs and those from effector and memory-like ILC2s isolated from mediastinal lymph node

Project description:Group 2 innate lymphoid cells (ILC2s) in the lung are stimulated by inhaled allergens. ILC2s do not directly recognize allergens but they are stimulated by cytokines including interleukin (IL)-33 released by damaged epithelium.Lung ILC2s, upon stimulation, produce T helper 2 cell-type cytokines inducing T cell independent allergic lung inflammation. We now report that lung ILC2s, upon activation by an allergen or IL-33, acquire the properties of memory cells. The activated ILC2s initially proliferate and secrete cytokines, followed by a contraction phase as they stop producing cytokines. Nevertheless, some persist long after the resolution of the inflammation and acquire intrinsic capacities to react to unrelated allergens more vigorously than naÃ¯ve ILC2s, thus mediating a severe allergic lung inflammation. Gene expression profiles of the previously activated ILC2s show a gene signature of memory T cells. These antigen non-specific memory ILC2s may explain why asthma patients are often sensitized to multiple allergens. ILC2s were isolated from mouse lungs from naive and IL-33 injected mice 4 days, 14 days and 4 months after the initial treatment. RNA was extracted from those ILC2 populations and analyzed for gene expression profiles. RNA was also extracted from ILC2s isolated from lung draining mediastinal lymph node (mLN) 4 days and 14 days after IL-33 treatment.

2016-06-30 | E-GEOD-81700 | biostudies-arrayexpress

RNA sequencing of mesenteric lymph node ILC2s from non-treated mice

Project description:RNA sequencing of mesenteric lymph node ILC2s from non-treated mice

| PRJNA725492 | ENA